Dina Israelov
Advanced Practice Midwife · Brooklyn, NYNPI 1992130348
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Exeltis, USA Inc. at 26.9% of the total. Reporting peaked in 2024 at $921 and has fallen 71.1% since, to $266 in 2025. Among advanced practice midwife clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $23.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$665
- Astellas Pharma US Inc$414
- Evofem Biosciences, Inc.$252
- Biohaven Pharmaceutical Holding Company Ltd.$224
- Pfizer$141
- Organon$106
- plus $675 from 14 others
What the payments were for
- Food & beverage$2,26091%
- Education$2189%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 35 | $665 |
| Astellas Pharma US Inc | 12 | $414 |
| Evofem Biosciences, Inc. | 12 | $252 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $224 |
| Pfizer | 7 | $141 |
| Organon | 6 | $106 |
| GE HealthCare | 1 | $104 |
| Shield Therapeutics Inc | 4 | $99 |
| Sumitomo Pharma America, Inc. | 5 | $97 |
| Millicent US Inc | 3 | $75 |
| Mylan Pharmaceuticals Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $46 |
| Amarin Pharma, Inc. | 2 | $37 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Scynexis, Inc. | 2 | $34 |
| Myovant Sciences Inc. | 1 | $21 |
| AbbVie | 1 | $19 |
| Heartflow, Inc. | 1 | $18 |
| Biogen | 1 | $16 |
| Dysis Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$135
How this compares
$2,478 in reported general payments places this provider in the 95th percentile of 364 advanced practice midwife providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 45 | $18,812 |
| VeozahFezolinetant | 26 | $14,387 |
| MyrbetriqMirabegron | 11 | $5,647 |
| Estradiol | 51 | $4,180 |
| PremproEstrogen,con/M-Progest Acet | 11 | $2,614 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 131 | $2,261 |
| Metronidazole | 47 | $1,426 |
| Halobetasol Propionate | 38 | $1,293 |
| Terconazole | 32 | $838 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 51 | $502 |
| Nystatin | 37 | $373 |
| Fluconazole | 55 | $156 |
| ValacyclovirValacyclovir Hcl | 12 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin, Prempro | $141 | $21,42656 claims |
| Astellas Pharma US IncVeozah, Myrbetriq | $414 | $20,03337 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 364 advanced practice midwife providers in New York.
Other advanced practice midwife in Brooklyn
- Linda GagliotiBrooklyn$2K
- Elizabeth GallegoBrooklyn$2K
- Yuen ChanBrooklyn$1K
- Ericka Quezada YorkBrooklyn$1K
- Rebekah KorineBrooklyn$848
- Roberto RaudaBrooklyn$774
- Windi MuraszkaBrooklyn$673
- Devora ManneBrooklyn$580
- Caroline PasterBrooklyn$535
- Ilene MillerBrooklyn$487
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.